MSGZX
Price
$18.25
Change
-$0.12 (-0.65%)
Updated
Jul 31 closing price
Net Assets
686.37M
NRGSX
Price
$60.89
Change
+$0.29 (+0.48%)
Updated
Jul 31 closing price
Net Assets
7.53B
Interact to see
Advertisement

MSGZX vs NRGSX

MSGZX vs NRGSX Comparison Chart in %
View a ticker or compare two or three
VS
MSGZX vs. NRGSX commentary
Aug 03, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MSGZX is a Buy and NRGSX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
NRGSX has more cash in the bank: 7.53B vs. MSGZX (686M). NRGSX pays higher dividends than MSGZX: NRGSX (0.45) vs MSGZX (0.00). MSGZX was incepted earlier than NRGSX: MSGZX (16 years) vs NRGSX (13 years). MSGZX (0.88) is less costly to investors than NRGSX (0.74). MSGZX is a more actively managed with annual turnover of: 76.00 vs. NRGSX (23.00). MSGZX (0) and NRGSX (0) have matching initial minimum investment requirements. MSGZX annual gain was more profitable for investors over the last year : 12.31 vs. NRGSX (-3.03). MSGZX return over 5 years is better than : -13.50 vs. NRGSX (-21.75).
MSGZXNRGSXMSGZX / NRGSX
Total Expense Ratio0.850.74115%
Annual Report Gross Expense Ratio0.880.74119%
Fund Existence16 years13 years-
Gain YTD20.14513.305151%
Front LoadN/AN/A-
Min. Initial Investment00-
Min. Initial Investment IRAN/AN/A-
Net Assets686M7.53B9%
Annual Yield % from dividends0.000.45-
Returns for 1 year12.31-3.03-406%
Returns for 3 years29.10-1.68-1,733%
Returns for 5 years-13.50-21.7562%
Returns for 10 years45.9313.23347%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
OMSOX32.530.27
+0.84%
Invesco Main Street All Cap A
FTDWX14.67N/A
N/A
Fidelity Advisor Asset Manager 20% M
DAABX25.18-0.07
-0.28%
DFA US Sustainability Targeted Val Instl
GMWEX13.37-0.11
-0.80%
GuideMark® World ex-US Service
LHCOX23.61-0.41
-1.71%
Lord Abbett Health Care F3